参考文献/References:
［1］ FARRAND K F,FRIDMAN M,STILLMAN I ,SCHAUMBERG D A.Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older ［J］.Am J Ophthalmol,2017,182:90-98.
［2］ 邵毅,石文卿.2018美国眼科学会干眼指南解读［J］.眼科新进展,2019,39(12):1101-1104.
SHAO Y,SHI W Q.Interpretation of 2018 dry eye syndrome preferred practice pattern ( DEsPPP) ［J］.Rec Adv Ophthalmol,2019,39(12):1101-1104.
［3］ STAPLETON F,ALVES M,BUNYA V Y,JALBERT I,LEKHANONT K,MALET F,MALET F,et al.TFOS DEWS II Epidemiology report ［J］.Ocul Surf,2017,15(3):334-365.
［4］ VAN S G,LABETOULLE M,BAUDOUIN C,ROLANDO M.Evidence of seasonality and effects of psychrometry in dry eye disease ［J］.Acta Ophthalmol,2016,94(5):499-506.
［5］ 孙爱丽,丛海涛,陈玲阳,马德华,王明仓.炎症反应在糖尿病及心血管并发症中的机制研究进展［J］.中国现代医生, 2018,56(28):159-164.
SUN A L,CONG H T,CHEN L Y,MA D H,WANG M C.Advances in research on the mechanism of inflammatory response in diabetes and cardiovascular complications ［J］.Chin Mod Doc,2018,56(28):159-164.
［6］ STERN M E,SCHAUMBURG C S,PFLUGFELDER S C.Dry eye as a mucosal autoimmune disease ［J］.Int Rev Immunol,2013,32(1):19-41.
［7］ STEVENSON W,CHAUHAN S K,DANA R.Dry eye disease:an immune-mediated ocular surface disorder ［J］.Arch Ophthalmol,2012,130(1):90-100.
［8］ 邵毅.国际干眼新共识(TFOSDEWS Ⅱ)解读［J］.眼科新进展,2018,38(1):1-12.
SHAO Y.Interpretation of TFOS DEWSⅡ［J］．Rec Adv Ophthalmol,2018,38(1):1-12.
［9］ KNOP E,KNOP N,MILLAR T,OBATA H,SULLIVAN D A.The international workshop on meibomian gland dysfunction:report of the subcommittee on anatomy,physiology,and pathophysiology of the meibomian gland ［J］.Invest Ophthalmol Vis Sci,2011,52(4):1938-1978.
［10］ LAM S M,TONG L,DUAN X,ACHARYA U R,TAN J H,PETZNICK A,et al. Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction ［J］.J Lipid Res,2014,55(9):1959-1969.
［11］ BUTOVICH I A,LU H,MCMAHON A,KETELSON H,SENCHYNA M,MEADOWS D,et al.Biophysical and morphological evaluation of human normal and dry eye meibum using hot stage polarized light microscopy ［J］.Invest Ophthalmol Vis Sci,2014,55(1):87-101.
［12］ SOLOMON A,DURSUN D,LIU Z,XIE Y,MACRI A,PFLUGFELDER S C.Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease ［J］.Invest Ophthalmol Vis Sci,2001,42(10):2283-2292.
［13］ NEBBIOSO M,DEL R P,GHARBIYA M,SACCHETTI M,PLATEROTI R,LAMBIASE A.Analysis of the pathogenic factors and management of dry eye in ocular surface disorders ［J］.Int J Mol Sci,2017,18(8):1764.
［14］ DAMASCENO R W,OSAKI M H,DANTAS P E,BELFORT R J.Involutional entropion and ectropion of the lower eyelid:prevalence and associated risk factors in the elderly population ［J］.Ophthalmic Plast Reconstr Surg,2011,27(5):317-320.
［15］ MELLER D,TSENG S C.Conjunctivochalasis:literature review and possible pathophysiology ［J］.Surv Ophthalmol,1998,43(3):225-232.
［16］ DI P M A,ESPANA E M,KAWAKITA T,TSENG S C.Clinical characteristics of conjunctivochalasis with or without aqueous tear deficiency ［J］.Br J Ophthalmol,2004,88(3):388-392.
［17］ ROSZKOWSKA A M,COLOSI P,FERRERI F M,GALASSO S.Age-related modifications of corneal sensitivity ［J］.Ophthalmologica,2004,218(5):350-355.
［18］ YOON K C,JEONG I Y,PARK Y G,YANG S Y.Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome ［J］.Cornea,2007,26(4):431-437.
［19］ GOTO E,MATSUMOTO Y,KAMOI M,ENDO K,ISHIDA R,DOGRU M,et al.Tear evaporation rates in Sjgren syndrome and non-Sjgren dry eye patients ［J］.Am J Ophthalmol,2007,144(1):81-85.
［20］ NEBBIOSO M,DEL R P,GHARBIYA M,SACCHETTI M,PLATEROTI R,LAMBIASE A.Analysis of the pathogenic factors and management of dry eye in ocular surface disorders ［J］.Int J Mol Sci,2017,18(8):1764.
［21］ 王家琦,翟玥,刘泽豫,颜一瑞,夏嘉阳,邓国英.大学生电子产品使用与视疲劳发生的相关性分析［J］.眼科新进展,2018,38(1):65-68.
WANG J Q，ZHAI Y，LIU Z Y，YAN Y R，XIA J Y，DENG G Y.Association of electronic devices usage and visual fatigue in Chinese college students ［J］.Rec Adv Ophthalmol,2018,38(1):65-68.
［22］ NEBBIOSO M,FAMELI V,GHARBIYA M,SACCHETTI M,ZICARI A M,LAMBIASE A.Investigational drugs in dry eye disease ［J］.Expert Opin Investig Drugs,2016,25(12):1437-1446.
［23］ AMBRSIO R J,TERVO T,WILSON S E.LASIK-associated dry eye and neurotrophic epitheliopathy:pathophysiology and strategies for prevention and treatment ［J］.J Refract Surg,2008,24(4):396-407.
［24］ LI X M,HU L,HU J,WANG W.Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery ［J］.Cornea,2007,9(1):16-20.
［25］ CRAIG J P,NICHOLS K K,AKPEK E K,CAFFERY B,DUA H S,JOO C K,et al.TFOS DEWS II definition and classification report ［J］.Ocul Surf,2017,15(3):276-283.
［26］ WANG Y,XU Z,GONG Q,REN W,CHEN L,LU F,et al.The role of different tear volume detection methods in the evaluation and diagnosis of mild dry eye disease ［J］.Transl Vis Sci Technol,2022,11(3):15.
［27］ RASHID M A K M,THIA Z Z,TEO C H Y,MAMUN S,ONG H S,TONG L.Evaluation of strip meniscometry and association with clinical and demographic variables in a community eye study (in Bangladesh) ［J］.J Clin Med,2020,9(10):3366.
［28］ SINGH A,VANATHI M,KISHORE A,GUPTA N,TANDON R.Evaluation of strip meniscometry,tear meniscus height and depth in the diagnosis of dry eye disease in Asian Indian eyes ［J］.Ocul Surf,2019,17(4):747-752.
［29］ ROLANDO M,CANTERA E,MENCUCCI R,RUBINO P,ARAGONA P.The correct diagnosis and therapeutic management of tear dysfunction:recommendations of the P.I.C.A.S.S.O.board ［J］.Int Ophthalmol,2018,38(2):875-895.
［30］ DREW V J,TSENG C L,SEGHATCHIAN J,BURNOUF T.Reflections on dry eye syndrome treatment:therapeutic role of blood products ［J］.Front Med (Lausanne),2018,5:33.
［31］ CELEBI A R,ULUSOY C,MIRZA G E.The efficacy of autologous serum eye drops for severe dry eye syndrome:a randomized double-blind crossover study ［J］.Graefes Arch Clin Exp Ophthalmol,2014,252(4):619-626.
［32］ HUSSAIN M,SHTEIN R M,SUGAR A,SOONG H K,WOODWARD M A,DELOSS K,et al.Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease ［J］.Cornea,2014,33(12):1245-1251.
［33］ 邵毅,吴康瑞,叶蕾.干眼的发病机制及治疗研究进展［J］.眼科新进展,2020,40(4):301-306.
SHAO Y，WU K R，YE L .Recent advance in dry eye pathogenesis and treatment ［J］.Rec Adv Ophthalmol,2020,40(4):301-306.
［34］ SUSARLA R,LIU L,WALKER E A,BUJALSKA I J,ALSALEM J,WILLIAMS G P,et al.Cortisol biosynthesis in the human ocular surface innate immune response ［J］.PLoS One,2014,9(4):e94913.
［35］ ROLANDO M,VAGGE A.Safety and efficacy of cortisol phosphate in hyaluronic acid vehicle in the treatment of dry eye in Sjgren syndrome ［J］.J Ocul Pharmacol Ther,2017,33(5):383-390.
［36］ HUANG L,GAO H,WANG Z,ZHONG Y,HAO L,DU Z.Combination nanotherapeutics for dry eye disease treatment in a rabbit model ［J］.Int J Nanomedicine,2021,16:3613-3631.
［37］ 蔡伟浩,彭玲,陆晓和,吴伟,李妍,李阳.omega-3治疗大鼠干眼的实验研究［J］.眼科新进展,2016,36(9):801-805.
CAI W H，PENG L，LU X H，WU W，LI Y，LI Y.Effects of omega-3 for dry eye in rats ［J］.Rec Adv Ophthalmol,2016,36(9):801-805.
［38］ CORTINA M S,HE J,LI N,BAZAN N G,BAZAN H E.Neuroprotectin D1 synthesis and corneal nerve regeneration after experimental surgery and treatment with PEDF plus DHA ［J］.Invest Ophthalmol Vis Sci,2010,51(2):804-810.
［39］ 钟先锋,陆丽珠,陈韵,黄伟志,黄桂东.ω-3多不饱和脂肪酸促眼部健康研究进展［J］.中国油脂,2018,43(7):129-134.
ZHONG X F，LU L Z，CHEN Y，HUANG W Z，HUANG G D.Progress in ω-3 polyunsaturated fatty acids promoting eye health ［J］.China Oils Fats,2018,43(7):129-134.
［40］ BARABINO S,HORWATH-WINTER J,MESSMER E M,ROLANDO M,ARAGONA P,KINOSHITA S.The role of systemic and topical fatty acids for dry eye treatment ［J］.Prog Retin Eye Res,2017,61:23-34.
［41］ 刘芳.普拉洛芬联合人工泪液对干眼症患者的临床效果及对炎性因子的影响［J］.贵州医药,2020,44(2):247-248.
LIU F.Clinical effect of pralprofen combined with artificial tear on patients with dry eye and its effect on inflammatory factors ［J］.Guizhou Med J,2020,44(2):247-248.
［42］ FOULKS G N,BORCHMAN D,YAPPERT M,KAKAR S.Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction:a comparative clinical and spectroscopic pilot study ［J］.Cornea,2013,32(1):44-53.
［43］ 申海静,陈铁红.玻璃酸钠联合环孢素A治疗混合型干眼症的疗效观察［J］.国际眼科杂志,2020,20(6):1031-1034.
SHEN H J,CHEN T H.Clinical effect of sodium hyaluronate and cyclosporine A eye drops for combination treatment of mixed dry eye syndrome ［J］.Int Eye Sci,2020,20(6):1031-1034.
［44］ 吴爱红,王炳亮,裴森.环孢霉素A在治疗重症干眼中的作用［J］.国际眼科杂志,2009,9(2):389-390.
WU A H,WANG B L,PEI S.Effect of cyclosporin A in the treatment of severe dry eye syndrome ［J］.Int Eye Sci,2009,9(2):389-390.
［45］ 苏映雪,王海英,曾夏芸,王延东.他克莫司滴眼液对碱烧伤兔干眼症疗效的实验研究［J］.今日药学,2015,25(10):681-683,687.
SU Y X,WANG H Y,ZENG X Y,WANG Y D.Study on alkali burn dry eye treated with tacrolimus eye drops in rabbits ［J］.Pharm Tod,2015,25(10):681-683,687.
［46］ PEREZ V L,PFLUGFELDER S C,ZHANG S,SHOJAEI A,HAQUE R.Lifitegrast,a novel integrin antagonist for treatment of dry eye disease ［J］.Ocul Surf,2016,14(2):207-215.
［47］ GOYAL S,HAMRAH P.Understanding neuropathic corneal pain--gaps and current therapeutic approaches ［J］.Semin Ophthalmol,2016,31(1-2):59-70.
［48］ OHSUMI Y.Historical landmarks of autophagy research ［J］.Cell Res,2014,24(1):9-23.
［49］ FARISELLI C,GIANNACCARE G,FRESINA M,VERSURA P.Trehalose/hyaluronate eyedrop effects on ocular surface inflammatory markers and mucin expression in dry eye patients［J］.Clin Ophthalmol, 2018,12:1293-1300.
［50］ 张飞.基于透明质酸粘多糖的功能性材料及其应用研究［D］.上海：上海交通大学,2014.
ZHANG F.Functional materials based on the mucopolysaccharide of hyaluronan and their applications［D］.Shanghai:Shanghai Jiao Tong University,2014.
［51］ ROSS A R,AL-AQABA M A,ALMAAZMI A,MESSINA M,NUBILE M,MASTROPASQUA L,et al.Clinical and in vivo confocal microscopic features of neuropathic corneal pain ［J］.Br J Ophthalmol,2020,104(6):768-775.
［52］ 邵毅.血清滴眼液治疗严重眼表疾病:英国皇家科学院临床规范指南解读［J］.眼科新进展,2020,40(2):101-104.
SHAO Y.Interpretation of guidelines for clinical standards of RCO serum eye drops in treatment of severe ocular surface disease ［J］.Rec Adv Ophthalmol,2020,40(2):101-104.
［53］ 师丹娜,丁瞳,邱伟强.治疗性角膜接触镜的发展及临床应用［J］.国际眼科杂志,2018,18(2):271-274.
SHI D N,DING T,QIU W Q.Development and clinical applications of therapeutic contact lenses ［J］.Int Eye Sci,2018,18(2):271-274.
［54］ GOYAL S,HAMRAH P.Understanding neuropathic corneal pain-gaps and current therapeutic approaches ［J］.Semin Ophthalmol,2016,31(1-2):59-70.
［55］ ZHANG Z,YANG W Z,ZHU Z Z,HU Q Q,CHEN Y F,HE H,et al.Therapeutic effects of topical doxycycline in a benzalkonium chloride-induced mouse dry eye model ［J］.Invest Ophthalmol Vis Sci,2014,55(5):2963-2974.
［56］ GARRETT Q,SIMMONS P A,XU S,VEHIGE J,ZHAO Z,EHRMANN K,et al.Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing ［J］.Invest Ophthalmol Vis Sci,2007,48(4):1559-1567.
［57］ ROLANDO M,AUTORI S,BADINO F,BARABINO S.Protecting the ocular surface and improving the quality of life of dry eye patients:a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients ［J］.J Ocul Pharmacol Ther,2009，25(3):271-278.
［58］ LANE S S,DUBINER H B,EPSTEIN R J,ERNEST P H,GREINER J V,HARDTEN D R,et al.A new system,the LipiFlow,for the treatment of meibomian gland dysfunction ［J］.Cornea,2012,31(4):396-404.
［59］ 戴鹏飞,李颖,田芳,王玉倩,倪珊珊,王洁.强脉冲光联合睑板腺按摩与眼睑熏蒸按摩治疗MGD相关干眼的疗效对比 ［J］.国际眼科杂志,2019,19(12):2101-2106.
DAI P F,LI Y,TIAN F,WANG Y Q,NI S S,WANG J.Efficacy comparison of intense pulsed light combined with meibomian gland massage and eyelid fumigation massage in the treatment of MGD-related dry eyes ［J］.Int Eye Sci,2019,19(12):2101-2106.
［60］ TOYOS R,MCGILL W,BRISCOE D.Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study ［J］.Photomed Laser Surg,2015,33(1):41-46.
［61］ GIANNACCARE G,TARONI L,SENNI C,SCORCIA V.Intense pulsed light therapy in the treatment of meibomian gland dysfunction:current perspectives ［J］.Clin Optom (Auckl),2019,11:113-126.
［62］ MASKIN S L.Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction ［J］.Cornea,2010,29(10):1145-1152.
［63］ INCEKALAN T K,HARBIYELI I I,YAGMUR M,ERDEM E.Effectiveness of intraductal meibomian gland probing in addition to the conventional treatment in patients with obstructive meibomian gland dysfunction ［J］.Ocul Immunol Inflamm,2019,27(8):1345-1351.
［64］ HE J,PHAM T L,KAKAZU A,BAZAN H E P.Recovery of corneal sensitivity and increase in nerve density and wound healing in diabetic mice after PEDF Plus DHA treatment［J］.Diabetes,2017,66(9):2511-2520.
［65］ ROMANO M R,BIAGIONI F,CARRIZZO A,LORUSSO M,SPADARO A,MICELLI F T,et al.Effects of vitamin B12 on the corneal nerve regeneration in rats ［J］.Exp Eye Res,2014,120:109-117.
［66］ VERSURA P,PROFAZIO V,GIANNACCARE G,FRESINA M,CAMPOS E C.Discomfort symptoms reduction and ocular surface parameters recovery with artelac rebalance treatment in mild-moderate dry eye［J］.Eur J Ophthalmol,2013,23(4):488-495.
［67］ 霍灿明,萧少雄,袁启贤,柳灿.维生素A和环孢素A治疗干眼症的临床对比分析［J］.心电图杂志(电子版),2019,8(4):118-119.
HUO C M,XIAO S X,YUAN Q X,LIU C.Clinical comparative analysis of vitamin A and cyclosporine A in the treatment of dry eye ［J］.J Electrocard(Electronic Edition),2019,8(4):118-119.
［68］ 朱小敏,唐双军,奚超.石斛夜光丸联合玻璃酸钠滴眼液及维生素AD软胶囊治疗干眼症临床评价［J］.中国药业,2020,29(8):100-102.
ZHU X M,YANG S J,XI C.Dendrobium noctilum pills combined with sodium hyaluronate eye drops and vitamin AD softgels in the treatment of dry eye ［J］.Chin Pharmaceu,2020,29(8):100-102.
［69］ 张丽娟,梁荣斌,邵毅.维生素D缺乏与干眼关系的研究进展［J］.眼科新进展，2021,41(8):794-796,800.
ZHANG L J,LIANG R B,SHAO Y.Relationship between vitam in D deficiency and dry eye disease［J］.Invest Ophthalmol Vis Sci,2021,41(8):794-796,800.
［70］ YANG C H,ALBIETZ J,HARKIN D G,KIMLIN M G,SCHMID K L.Impact of oral vitamin D supplementation on the ocular surface in people with dry eye and/or low serum vitamin D ［J］.Cont Lens Anterior Eye,2018,41(1):69-76.
［71］ ARAGONA P,RANIA L,ROSZKOWSKA A M,SPINELLA R,POSTORINO E,PUZZOLO D,et al.Effects of amino acids enriched tears substitutes on the cornea of patients with dysfunctional tear syndrome［J］.Acta Ophthalmol,2013,91(6):e437-e444.
［72］ ARAGONA E,RANIA L,POSTORINO E I,INTERDONATO A,GIUFFRIDA R,CANNAV S P,et al.Tear film and ocular surface assessment in psoriasis ［J］.Br J Ophthalmol,2018,102(3):302-308.